Oppenheimer Asset Management’s Sangamo Therapeutics SGMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q2 | – | Sell |
-26
| Closed | – | – | 1377 |
|
|
2020
Q1 | $0 | Sell |
26
-16,457
| -100% | – | ﹤0.01% | 1621 |
|
|
2019
Q4 | $138K | Buy |
16,483
+617
| +4% | +$5.17K | ﹤0.01% | 1139 |
|
|
2019
Q3 | $144K | Buy |
15,866
+1,831
| +13% | +$16.6K | ﹤0.01% | 1111 |
|
|
2019
Q2 | $151K | Buy |
14,035
+1,003
| +8% | +$10.8K | ﹤0.01% | 1118 |
|
|
2019
Q1 | $124K | Buy |
13,032
+4,184
| +47% | +$39.8K | ﹤0.01% | 1156 |
|
|
2018
Q4 | $102K | Buy |
+8,848
| New | +$102K | ﹤0.01% | 1186 |
|
|
2017
Q4 | – | Sell |
-6,274
| Closed | -$94K | – | 1420 |
|
|
2017
Q3 | $94K | Sell |
6,274
-1,472
| -19% | -$22.1K | ﹤0.01% | 1218 |
|
|
2017
Q2 | $68K | Buy |
7,746
+415
| +6% | +$3.64K | ﹤0.01% | 1281 |
|
|
2017
Q1 | $38K | Buy |
+7,331
| New | +$38K | ﹤0.01% | 1395 |
|